Visa CDR (CAD Hedged)
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 28.8K
- Market Cap
- -
- Introduction
Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.
FDA Approves Roche's PATHWAY HER2 Test as Companion Diagnostic for HER2-Positive Biliary Tract Cancer
• The FDA has approved Roche's PATHWAY HER2 (4B5) test to identify biliary tract cancer (BTC) patients eligible for ZIIHERA, a HER2-targeted therapy.
• This marks the first FDA-approved companion diagnostic for HER2 status assessment in BTC, addressing a critical gap in personalized medicine for this cancer.
• Biliary tract cancer has a poor prognosis due to late diagnosis and limited treatment options, making this approval a significant step forward.
• The PATHWAY HER2 test expands its clinical utility, previously used for breast cancer, to now guide HER2-targeted therapy in BTC patients.
© Copyright 2025. All Rights Reserved by MedPath